Although these large-scale studies were conducted in the general population rather than in patients with acromegaly, they provide important external validation of the GH/IGF-1–breast cancer link, reinforcing the biological connection of an effect in acromegaly even though direct cohort evidence remains unclear (39– 41). Here, IGF1 is linked to breast carcinoma.